基本信息
views: 201
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Peter Rieckmann, MD, FRCPC, FAAN, FEAN
Peter Rieckmann received his medical degree from the University of Göttingen, Germany in 1988. After a postdoctoral fellowship in molecular immunology at the NIH, Bethesda, USA he completed his training in Neurology at the National Institute for Nervous Disease, London, UK and the University of Göttingen, Germany. Professor Rieckmann received German Board certification in Neurology in 1995. His academic and clinical positions have included Senior (staff) Neurologist and Professor for Neurology, Dept. of Neurology, as well as head of the Clinical Research Group for Multiple Sclerosis and Neuroimmunology, at the Julius-Maximilians University of Würzburg.
In 2007 Professor Rieckmann became the Multiple Sclerosis Society of Canada Research Chair and Director of the MS Program and Full Tenured Professor at the University of British Columbia, Vancouver, Canada. Under his leadership the Vancouver MS clinical research program was awarded Western-Pacific Research and Training Center by the MS Society of Canada. He is a founding member of the EndMS campaign in Canada and was instrumental in establishing the Center for Brain Health at UBC in Vancouver (http://www.centreforbrainhealth.ca).
In September 2009 he started a new position as Chair of the Department of Neurology at the Academic Hospital in Bamberg, and Professor of Neurology at the University of Erlangen, Germany. Since 2012 he also serves as deputy medical director of the Academic Hospital in Bamberg. In the same year he started the MS in the 21st century steering group, a think tank of international experts and people with MS working on innovative principles of MS care and patient engagement.
Together with colleagues from cardiology, psychiatry, neurosurgery, vascular medicine and neuroradiology he raised funds for Germany’s first Heart and Brain Center.
In 2017 Prof. Rieckmann became medical director and head of the Hospital for Nervous diseases at Medical Park Loipl/Bavaria. There he has recently established the first German Center for Clinical Neuroplasticity and developed innovative digital tools for objective outcome parameters in neurorehabilitation as well as an interactive digital neurorehabilitation assistant.
His major research interests are disease modifying factors and repair mechanisms in multiple sclerosis and stroke as well as improvement of rehabilitation strategies to facilitate neuroplasticity and to promote patient engagement in acute and chronic neurological diseases.
Professor Rieckmann is a Fellow of the Royal College of Physicians and Surgeons Canada (FRCPC), Fellow of the American Academy of Neurology (FAAN) and European Academy of Neurology (FEAN). He holds several positions as visiting professor across the globe. He has received numerous awards - including Gerhard Hess prize of the German Research Association (DFG) - and research grants with over 280 papers to his credit in peer-reviewed medical journals.
Publication list: https://www.ncbi.nlm.nih.gov/pubmed/?term=rieckmann++p
Research Interests
Papers共 486 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Strokeno. 1 (2024): 146-155
Advances in therapyno. 12 (2023): 5131-5136
Journal of neuroengineering and rehabilitationno. 1 (2023): 1-15
Hayder K. Hassoun,Akram Almahdawi,Murad Al-Naqshbandi, Sarwer Jamal Al-Bajalan,Nawfal M. Sheaheed,Mohammad A.S. Kamil, Samer Mohammed Saeed Ridha, Mazin M.H. Al-Owath,Anmar Oday Hatem,Peter Rieckmann
Multiple Sclerosis and Related Disordersno. 2 (2023): 105171-e13350
CASE REPORTS IN NEUROLOGYno. 1 (2023): 163-171
Neurodegenerative disease managementno. 6 (2022): 295-301
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn